For years, scientists have puzzled over a contradiction. Cannabis is famous for stimulating appetite, the effect most people know as the "munchies." Yet large population studies have repeatedly observed that regular cannabis users tend to carry less body weight and show healthier markers of metabolic health than non-users. Two studies published in 2026 take a fresh look at that paradox, and the early findings are worth understanding for anyone in New York who follows cannabis and wellness.
A quick caution before we dig in: this is an emerging and genuinely complicated area of science. The research below is observational or preclinical, which means it can show patterns but cannot prove that cannabis causes any health outcome. Nothing here is medical advice, and the scientists involved are clear that their work does not support using cannabis to manage weight or any metabolic condition.
A Large 2026 Population Study
One of the most substantial recent contributions comes from researchers at Zhejiang University and Taizhou First People's Hospital, published in the journal Nutrition, Metabolism and Cardiovascular Diseases.[1] The team analyzed data from 91,002 participants in the UK Biobank, all of whom were free of metabolic disease when the study began.
After adjusting for a range of factors, the analysis found that cannabis use was associated with a modestly lower risk of developing metabolic disease overall. The researchers reported a 7% lower risk of hypertension and an 18% lower risk of type 2 diabetes among users, with the most pronounced association appearing among heavy users for obesity risk.
It is important to read these numbers the way the researchers intended. Observational studies like this one can reveal associations, but they cannot rule out other explanations, such as differences in age, activity levels, or lifestyle between people who use cannabis and people who do not. Studies indicate a relationship here, not a proven cause and effect.
The Body Weight Catch
The same 2026 analysis found that the picture changes dramatically depending on body mass index. Among people with a BMI below 25, cannabis use was more strongly associated with reduced risk across several conditions. Among people with a BMI over 30, the relationship reversed: moderate use was instead linked to a higher reported risk of metabolic disease and hypertension.[1] The study also found no meaningful association with cholesterol disorders or fatty liver disease.
That reversal is a useful reminder that "cannabis and metabolism" is not a single story with a single answer. The same behavior appears to relate to health very differently from one person to the next, which is exactly why researchers describe the relationship as complex rather than simply protective.
Why the Whole Plant May Matter More Than THC Alone
The most intriguing 2026 finding may come from a preclinical study at the University of California, Riverside, led by Professor Nicholas DiPatrizio and published in The Journal of Physiology.[2] His team set out to investigate the appetite paradox directly, using a mouse model designed to mimic human dietary patterns.
The researchers compared two treatments: pure delta-9 THC, the primary psychoactive compound in cannabis, and a whole-plant cannabis extract containing the same amount of THC alongside the plant's other naturally occurring compounds. Both treatments produced significant weight loss in obese mice. But the metabolic outcomes diverged sharply.
Mice given THC alone lost weight yet showed no improvement in glucose regulation, a key marker tied to type 2 diabetes. Mice given the whole-plant extract lost weight and experienced a reversal of those metabolic impairments. The analysis pointed to a signaling pathway between fat tissue and the pancreas that the full extract appeared to restore more effectively than THC by itself.[2]
"This suggests that THC alone is not responsible for the metabolic benefits associated with cannabis use," DiPatrizio said in the university's announcement. "Other compounds in the plant appear to play a critical role."[3] He was equally direct about the limits of the work, adding, "We're not suggesting people should use cannabis to manage weight or diabetes."[3]
The Whole-Plant Idea and the Entourage Effect
If you have read our piece on the entourage effect, the UC Riverside results may sound familiar. The entourage concept holds that cannabis works as a chemical ensemble, with cannabinoids and terpenes interacting rather than acting in isolation. Early laboratory research has suggested that some terpenes are themselves biologically active and can influence how cannabinoids behave in the body.[4]
The metabolism findings are far from settled, but they fit a broader theme running through recent cannabis science: the full plant and its many compounds may behave differently than any single isolated molecule. This is part of why we treat the whole flower, and its complete chemical profile, as worth understanding rather than reducing everything to a THC percentage. Earlier population research, including work published more than a decade ago, also linked cannabis use to lower fasting insulin and measures of insulin resistance, which is part of what motivated this newer line of inquiry.[5]
How to Think About This Responsibly
It is easy to read a headline about diabetes risk and draw a conclusion the science does not support. So a few grounding points are worth repeating. The human data is observational, so it shows associations rather than proof. The most striking metabolic results come from mice, not people. And the population findings flip direction depending on body weight, which means there is no one-size-fits-all takeaway.
Cannabis is not a weight-management tool or a treatment for any metabolic condition, and it should never replace guidance from a qualified clinician. If you live with a condition like type 2 diabetes or high blood pressure, talk with your doctor before making any changes, including changes to cannabis use. What this research does offer is a clearer map of where the science is heading and which questions deserve careful study next.
The Bottom Line
The 2026 research paints cannabis and metabolic health as a relationship that is real, measurable, and genuinely complicated. Early findings show that regular users often have healthier metabolic profiles, that the whole plant may matter more than THC in isolation, and that individual factors like body weight can change the equation entirely. For a curious New York audience, it is a reminder that the most interesting cannabis stories are usually the ones that resist easy answers.
At Greenline Apothecary, we believe informed choices start with understanding what is actually in your flower. Every Greenline strain carries a detailed terpene and cannabinoid profile, so you can pay attention to the whole plant rather than a single number. Browse our full strain menu to see what is available, or find a licensed dispensary near you.
Frequently Asked Questions
What does 2026 research say about cannabis and metabolic health?
A 2026 analysis of 91,002 UK Biobank participants, published in Nutrition, Metabolism and Cardiovascular Diseases, found that cannabis use was associated with a modestly lower risk of several metabolic conditions, including a reported 7% lower risk of hypertension and an 18% lower risk of type 2 diabetes. The researchers stress these are observational associations, so causation cannot be established, and the relationship varied significantly by body mass index.
Why might the whole cannabis plant matter more than THC alone for metabolism?
In a 2026 UC Riverside preclinical study published in The Journal of Physiology, both pure THC and a whole-plant extract led to weight loss in obese mice, but only the whole-plant extract improved glucose regulation. The researchers suggest that compounds beyond THC, working together, may drive the metabolic benefits, an idea consistent with the entourage effect. These findings are early and have not been confirmed in humans.
Can cannabis be used to treat diabetes or to lose weight?
No. The researchers behind the 2026 studies explicitly caution against using cannabis to manage weight or diabetes. The human data is observational and the animal data is preclinical, so neither establishes cannabis as a treatment. Anyone with a metabolic condition should work with a qualified clinician before making any changes.
Does body weight change how cannabis relates to metabolic risk?
In the 2026 UK Biobank analysis, body mass index played a major role. Among people with a BMI below 25, cannabis use was more strongly associated with reduced risk across several conditions. Among people with a BMI over 30, moderate use was instead linked to higher reported risk of metabolic disease and hypertension. This is one reason researchers describe the relationship as complex rather than straightforwardly protective.
References
- Researchers at Women's Hospital School of Medicine, Zhejiang University, and Taizhou First People's Hospital. Associations between cannabis use and risk of metabolic disease in the UK Biobank. Nutrition, Metabolism and Cardiovascular Diseases. 2026. Reported via The Marijuana Herald. themarijuanaherald.com
- Avalos B, Olmos M, Wood CP, et al. Delta-9 THC and cannabis extracts differentially improve adipoinsular dysfunction in diet-induced obesity. The Journal of Physiology. 2026. doi:10.1113/JP290431
- Pittalwala I. Cannabis compounds may boost metabolic health while supporting weight loss. UC Riverside News. May 12, 2026. news.ucr.edu
- LaVigne JE, Hecksel R, Keresztes A, et al. Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. Scientific Reports. 2021;11:8232. doi:10.1038/s41598-021-87740-8
- Penner EA, Buettner H, Mittleman MA. The impact of marijuana use on glucose, insulin, and insulin resistance among US adults. The American Journal of Medicine. 2013;126(7):583-589. doi:10.1016/j.amjmed.2013.03.002
This article is for general educational purposes only and is not medical advice. Cannabis affects everyone differently. Consult a qualified healthcare provider about your individual health, especially if you have a metabolic condition. For adults 21 and older.
Know what's in your flower.
Explore Greenline Strains